About Us

  Founded by two current sophomores in college, our aim
 is to treat Duchenne Muscular Dystrophy using under-explored protein
 therapeutics. Some might see our age as a drawback, but we are
 extremely motivated and have cultivated strong connections throughout
 both the neuromuscular and broader life-sciences world. We are not traditional biotech entrepreneurs, we are not afraid
 to take risks and we will pursue our ideas relentlessly. Check out the "Our
 Approach" tab to learn more. 

Duchenne Muscular Dystrophy

Our Approach

Co-Founders


Shivin Kumar

Co-Founder, CEO

Shivin Kumar, a sophomore at Tufts University, has been thinking about an idea for treating Duchenne Muscular Dystrophy since seventh grade when he heard a podcast about it. Since then, he has founded Uplands Med and for the past few months, he and fellow senior Malyka Ram have advanced the idea further, and have won the first MBC BioLabs “Golden Ticket” sponsored by Mission BioCapital.


He has worked at the Engleman Lab at Stanford University where he learned basic lab techniques and experiments. After working at MBC Biolabs in San Carlos, he is continuing the company lab work at Watertown Biolabs —close to Tufts.


Malyka Ram

Co-Founder

Malyka Ram is a sophomore at Purdue University, she has loved biology ever since her mother gifted her pop out anatomy books when she was a child. She worked at the Alzheimer’s Disease Research Center at Stanford University at the beginning of high school, and is looking forward to exploring biomedical R&D through her and her peer’s research of Duchenne Muscular Dystrophy. After working at MBC Biolabs for a few months, she is looking to continue the company work at a lab at Purdue.


Special features

Contact us

Contact us

We're here to help! Send any questions you have over to us. We look forward to hearing from you.

Contact Us

Share by: